Figures & data
Table 1. Prevalences of hypercholesterolemia (%) or hypertriglyceridemia (%) in the Västerbotten Intervention Programme during four periods from 1990–2010. Prevalences are adjusted for age. The numbers in brackets represent the 99% confidence intervals for the adjusted prevalence
Fig. 1. Levels of (a) serum cholesterol (mmol/L) and (b) serum triglycerides (mmol/L) among adults in the Västerbotten Intervention Programme, 1990–2010. The levels are adjusted for age.
Fig. 2. Levels of (a) serum cholesterol (mmol/L) and (b) serum triglycerides (mmol/L) in the Västerbotten Intervention Programme, 1990–2010, across geographical areas. The levels are adjusted for age, educational levels and sex. The graphs represent two-year moving averages.
Fig. 3. Ten-year risk of developing (a) hypercholesterolemia and (b) hypertriglyceridemia among participants in the Västerbotten Intervention Programme. Risk is presented as a function of age at the start of the 10-year period and education, adjusted for baseline levels of cholesterol and triglycerides.
Note: The 30-year cohort during 1996–2000 is not presented as only few individuals were invited to the study since 1995. The 10-year risk was estimated using the predicted probability after logistic regression analysis for each sex, controlling for age and educational level.
Table 2. Proportions of men and women with hypercholesterolemia and hypertriglyceridemia during the baseline and 10-year follow-up periods in the Västerbotten Intervention Programme
Fig. 4. Proportions of individuals who reported taking lipid-lowering treatment in the Västerbotten Intervention Programme, 1990–2010. Proportions are adjusted for age.
Fig. 5. Proportions of men and women reporting use of lipid-lowering treatment who did not reach treatment goals of serum cholesterol < 5.0 mmol/L or serum triglycerides <1.7 mmol/L in the Västerbotten Intervention Program, 1990–2010. Proportions are adjusted for age. The graphs show two-year moving averages of the proportions.
